Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Glenn currently holds 11,937 shares of IRADIMED CORP (IRMD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Glenn has been a net seller of IRMD stock. They have purchased $0 and sold $2.5M worth of shares.
John Glenn's most recent insider trade was on Jun 20, 2026, when they sold 5,796 shares at $0.00 per share.
John Glenn serves as Executive at IRADIMED CORP (IRMD). They have executed 46 insider transactions totaling $2.5M over their tenure at the company.
John Glenn holds the position of Executive at IRADIMED CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
John Glenn has shown a selling trading pattern, with $0 in total purchases and $2.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John Glenn was on Dec 11, 2025, when they sold $1.4M worth of IRMD shares. This transaction involved 14,468 shares at $97.26 per share.
John Glenn currently owns 11,937 shares of IRADIMED CORP (IRMD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Glenn's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Glenn has 46 Form 4 filings on record as an insider at IRADIMED CORP.
Set alerts for John Glenn and 40,000+ other insiders.